BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34208103)

  • 1. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.
    Tu KH; Fan PY; Chen TD; Chuang WY; Wu CY; Ku CL; Tian YC; Yang CW; Fang JT; Yang HY
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review.
    Leurs A; Gnemmi V; Lionet A; Renaud L; Gibier JB; Copin MC; Hachulla E; Hatron PY; Launay D; Fajgenbaum D; Terriou L
    Front Immunol; 2019; 10():1489. PubMed ID: 31316523
    [No Abstract]   [Full Text] [Related]  

  • 3. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
    Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
    BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
    Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
    Zhou Q; Zhang Y; Zhou G; Zhu J
    BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siltuximab Monotherapy in Tafro Syndrome: A Case Report and Review of the Literature.
    Cordero L; Aguilar-Rodríguez F; Sandino J; Alonso M; Gutiérrez E
    J Nephrol; 2023 May; 36(4):1181-1185. PubMed ID: 36652167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
    Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
    CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal histological continuum of TAFRO syndrome: A case report and literature review.
    Uemura T; Matsui M; Kokubu M; Samejima KI; Tsuruya K
    Clin Nephrol; 2022 Feb; 97(2):121-128. PubMed ID: 34854374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Mizutani KI; Kumagai M; Shioya A; Guo X; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Kida M; Yamada S
    Pathol Res Pract; 2019 Mar; 215(3):410-413. PubMed ID: 30642741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal histology in a patient with TAFRO syndrome: a case report.
    Mizuno H; Sekine A; Oguro M; Oshima Y; Kawada M; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Hoshino J; Sawa N; Fujii T; Takaichi K; Ohashi K; Ubara Y
    Hum Pathol; 2018 Dec; 82():258-263. PubMed ID: 29626596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
    Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
    Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome.
    Ozeki T; Tsuji M; Yamamoto J; Shigematsu C; Maruyama S
    CEN Case Rep; 2018 Nov; 7(2):243-247. PubMed ID: 29766467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
    Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
    Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
    Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
    Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial Hemorrhage in a Patient with TAFRO Syndrome Treated with Cyclosporine A and Rituximab.
    Akagi Y; Kato T; Yamashita Y; Hosoi H; Murata S; Yamamoto S; Warigaya K; Nakao T; Murata S; Sonoki T; Tamura S
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report.
    Iwasaki T; Mizusaki K; Masumoto M; Minagawa Y; Azuma K; Furukawa T; Yoshida M; Kuragano T
    BMC Nephrol; 2022 Jul; 23(1):262. PubMed ID: 35870879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study.
    Nishimura Y; Hanayama Y; Fujii N; Kondo E; Otsuka F
    Intern Med J; 2020 Feb; 50(2):184-191. PubMed ID: 31211492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tufted-angioma-like lesion associated with vascular endothelial growth factor and interleukin-6 in TAFRO syndrome: Is it a common histological feature of multicentric Castleman disease/POEMS syndrome?
    Fujita K; Hatta K
    J Cutan Pathol; 2019 Apr; 46(4):280-284. PubMed ID: 30632181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase 3β/CCR6-positive bone marrow cells correlate with disease activity in multicentric Castleman disease-TAFRO.
    Abe N; Kono M; Kono M; Ohnishi N; Sato T; Tarumi M; Yoshimura M; Sato T; Karino K; Shimizu Y; Fujieda Y; Kato M; Hasebe R; Oku K; Murakami M; Atsumi T
    Br J Haematol; 2022 Mar; 196(5):1194-1204. PubMed ID: 34873687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To and TAFRO - a cryptic cause of acute renal failure: a case report.
    Shah N; Davidson T; Cheung C; Keung K
    BMC Nephrol; 2022 Jan; 23(1):19. PubMed ID: 34991522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.